Global Antiprotozoal Drugs Market Insights, Forecast to 2029
This report presents an overview of global market for Antiprotozoal Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Antiprotozoal Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antiprotozoal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antiprotozoal Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Antiprotozoal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Antiprotozoal Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Akthelia Pharmaceuticals Ltd, GlaxoSmithKline Plc, Immuron Ltd, Microbiotix Inc, Protein Potential LLC, Dr. Reddy’s Laboratories, Mission Pharmacal and Aceto Corp., etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Antiprotozoal Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiprotozoal Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiprotozoal Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Antiprotozoal Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antiprotozoal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antiprotozoal Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Antiprotozoal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Antiprotozoal Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Akthelia Pharmaceuticals Ltd, GlaxoSmithKline Plc, Immuron Ltd, Microbiotix Inc, Protein Potential LLC, Dr. Reddy’s Laboratories, Mission Pharmacal and Aceto Corp., etc.
By Company
- Sanofi
- Akthelia Pharmaceuticals Ltd
- GlaxoSmithKline Plc
- Immuron Ltd
- Microbiotix Inc
- Protein Potential LLC
- Dr. Reddy’s Laboratories
- Mission Pharmacal
- Aceto Corp.
- Mylan Pharmaceuticals
- Impax Laboratories
- Pfizer
- Lupin Pharmaceuticals
- Glenmark Pharmaceuticals
- Sun Pharmaceutical
- Heritage Pharmaceuticals
- Gilead Sciences
- Johnson & Johnson
- Bristol-Myers Squibb
- Profounda
- Knight Therapeutics
- Albert David
- Wanlong
- Fangsheng
- KPC Pharmaceuticals
- Guilin Pharmaceuticals
- Pude Pharmaceutica
- by Diseases
- Amoebic Dysentery
- Antimalarial Drug
- Leishmaniasis & Chagas Disease
- by Drugs
- Metronidazole
- Atovaquone
- Benznidazole
- Dehydroemetine
- Eflornithine
- Emetine
- Fenbendazole
- Iodoquinol
- Melarsoprol
- Others (like Meglumine antimonite, Nifurtimox, Pentamidine, etc.)
- Hospital
- Clinic
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Antiprotozoal Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiprotozoal Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiprotozoal Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiprotozoal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Amoebic Dysentery
1.2.3 Antimalarial Drug
1.2.4 Leishmaniasis & Chagas Disease
1.3 Market by Application
1.3.1 Global Antiprotozoal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Antiprotozoal Drugs Market Perspective (2018-2029)
2.2 Global Antiprotozoal Drugs Growth Trends by Region
2.2.1 Antiprotozoal Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antiprotozoal Drugs Historic Market Size by Region (2018-2023)
2.2.3 Antiprotozoal Drugs Forecasted Market Size by Region (2024-2029)
2.3 Antiprotozoal Drugs Market Dynamics
2.3.1 Antiprotozoal Drugs Industry Trends
2.3.2 Antiprotozoal Drugs Market Drivers
2.3.3 Antiprotozoal Drugs Market Challenges
2.3.4 Antiprotozoal Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Antiprotozoal Drugs by Players
3.1.1 Global Antiprotozoal Drugs Revenue by Players (2018-2023)
3.1.2 Global Antiprotozoal Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Antiprotozoal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Antiprotozoal Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Antiprotozoal Drugs Market Concentration Ratio
3.4.1 Global Antiprotozoal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiprotozoal Drugs Revenue in 2022
3.5 Global Key Players of Antiprotozoal Drugs Head office and Area Served
3.6 Global Key Players of Antiprotozoal Drugs, Product and Application
3.7 Global Key Players of Antiprotozoal Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ANTIPROTOZOAL DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Antiprotozoal Drugs Historic Market Size by Type (2018-2023)
4.2 Global Antiprotozoal Drugs Forecasted Market Size by Type (2024-2029)
5 ANTIPROTOZOAL DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Antiprotozoal Drugs Historic Market Size by Application (2018-2023)
5.2 Global Antiprotozoal Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Antiprotozoal Drugs Market Size (2018-2029)
6.2 North America Antiprotozoal Drugs Market Size by Type
6.2.1 North America Antiprotozoal Drugs Market Size by Type (2018-2023)
6.2.2 North America Antiprotozoal Drugs Market Size by Type (2024-2029)
6.2.3 North America Antiprotozoal Drugs Market Share by Type (2018-2029)
6.3 North America Antiprotozoal Drugs Market Size by Application
6.3.1 North America Antiprotozoal Drugs Market Size by Application (2018-2023)
6.3.2 North America Antiprotozoal Drugs Market Size by Application (2024-2029)
6.3.3 North America Antiprotozoal Drugs Market Share by Application (2018-2029)
6.4 North America Antiprotozoal Drugs Market Size by Country
6.4.1 North America Antiprotozoal Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Antiprotozoal Drugs Market Size by Country (2018-2023)
6.4.3 North America Antiprotozoal Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Antiprotozoal Drugs Market Size (2018-2029)
7.2 Europe Antiprotozoal Drugs Market Size by Type
7.2.1 Europe Antiprotozoal Drugs Market Size by Type (2018-2023)
7.2.2 Europe Antiprotozoal Drugs Market Size by Type (2024-2029)
7.2.3 Europe Antiprotozoal Drugs Market Share by Type (2018-2029)
7.3 Europe Antiprotozoal Drugs Market Size by Application
7.3.1 Europe Antiprotozoal Drugs Market Size by Application (2018-2023)
7.3.2 Europe Antiprotozoal Drugs Market Size by Application (2024-2029)
7.3.3 Europe Antiprotozoal Drugs Market Share by Application (2018-2029)
7.4 Europe Antiprotozoal Drugs Market Size by Country
7.4.1 Europe Antiprotozoal Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Antiprotozoal Drugs Market Size by Country (2018-2023)
7.4.3 Europe Antiprotozoal Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Antiprotozoal Drugs Market Size (2018-2029)
8.2 China Antiprotozoal Drugs Market Size by Type
8.2.1 China Antiprotozoal Drugs Market Size by Type (2018-2023)
8.2.2 China Antiprotozoal Drugs Market Size by Type (2024-2029)
8.2.3 China Antiprotozoal Drugs Market Share by Type (2018-2029)
8.3 China Antiprotozoal Drugs Market Size by Application
8.3.1 China Antiprotozoal Drugs Market Size by Application (2018-2023)
8.3.2 China Antiprotozoal Drugs Market Size by Application (2024-2029)
8.3.3 China Antiprotozoal Drugs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Antiprotozoal Drugs Market Size (2018-2029)
9.2 Asia Antiprotozoal Drugs Market Size by Type
9.2.1 Asia Antiprotozoal Drugs Market Size by Type (2018-2023)
9.2.2 Asia Antiprotozoal Drugs Market Size by Type (2024-2029)
9.2.3 Asia Antiprotozoal Drugs Market Share by Type (2018-2029)
9.3 Asia Antiprotozoal Drugs Market Size by Application
9.3.1 Asia Antiprotozoal Drugs Market Size by Application (2018-2023)
9.3.2 Asia Antiprotozoal Drugs Market Size by Application (2024-2029)
9.3.3 Asia Antiprotozoal Drugs Market Share by Application (2018-2029)
9.4 Asia Antiprotozoal Drugs Market Size by Region
9.4.1 Asia Antiprotozoal Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Antiprotozoal Drugs Market Size by Region (2018-2023)
9.4.3 Asia Antiprotozoal Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Antiprotozoal Drugs Introduction
11.1.4 Sanofi Revenue in Antiprotozoal Drugs Business (2018-2023)
11.1.5 Sanofi Recent Developments
11.2 Akthelia Pharmaceuticals Ltd
11.2.1 Akthelia Pharmaceuticals Ltd Company Details
11.2.2 Akthelia Pharmaceuticals Ltd Business Overview
11.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Introduction
11.2.4 Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2018-2023)
11.2.5 Akthelia Pharmaceuticals Ltd Recent Developments
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Introduction
11.3.4 GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2018-2023)
11.3.5 GlaxoSmithKline Plc Recent Developments
11.4 Immuron Ltd
11.4.1 Immuron Ltd Company Details
11.4.2 Immuron Ltd Business Overview
11.4.3 Immuron Ltd Antiprotozoal Drugs Introduction
11.4.4 Immuron Ltd Revenue in Antiprotozoal Drugs Business (2018-2023)
11.4.5 Immuron Ltd Recent Developments
11.5 Microbiotix Inc
11.5.1 Microbiotix Inc Company Details
11.5.2 Microbiotix Inc Business Overview
11.5.3 Microbiotix Inc Antiprotozoal Drugs Introduction
11.5.4 Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2018-2023)
11.5.5 Microbiotix Inc Recent Developments
11.6 Protein Potential LLC
11.6.1 Protein Potential LLC Company Details
11.6.2 Protein Potential LLC Business Overview
11.6.3 Protein Potential LLC Antiprotozoal Drugs Introduction
11.6.4 Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2018-2023)
11.6.5 Protein Potential LLC Recent Developments
11.7 Dr. Reddy’s Laboratories
11.7.1 Dr. Reddy’s Laboratories Company Details
11.7.2 Dr. Reddy’s Laboratories Business Overview
11.7.3 Dr. Reddy’s Laboratories Antiprotozoal Drugs Introduction
11.7.4 Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023)
11.7.5 Dr. Reddy’s Laboratories Recent Developments
11.8 Mission Pharmacal
11.8.1 Mission Pharmacal Company Details
11.8.2 Mission Pharmacal Business Overview
11.8.3 Mission Pharmacal Antiprotozoal Drugs Introduction
11.8.4 Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2018-2023)
11.8.5 Mission Pharmacal Recent Developments
11.9 Aceto Corp.
11.9.1 Aceto Corp. Company Details
11.9.2 Aceto Corp. Business Overview
11.9.3 Aceto Corp. Antiprotozoal Drugs Introduction
11.9.4 Aceto Corp. Revenue in Antiprotozoal Drugs Business (2018-2023)
11.9.5 Aceto Corp. Recent Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Details
11.10.2 Mylan Pharmaceuticals Business Overview
11.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Introduction
11.10.4 Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.10.5 Mylan Pharmaceuticals Recent Developments
11.11 Impax Laboratories
11.11.1 Impax Laboratories Company Details
11.11.2 Impax Laboratories Business Overview
11.11.3 Impax Laboratories Antiprotozoal Drugs Introduction
11.11.4 Impax Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023)
11.11.5 Impax Laboratories Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Antiprotozoal Drugs Introduction
11.12.4 Pfizer Revenue in Antiprotozoal Drugs Business (2018-2023)
11.12.5 Pfizer Recent Developments
11.13 Lupin Pharmaceuticals
11.13.1 Lupin Pharmaceuticals Company Details
11.13.2 Lupin Pharmaceuticals Business Overview
11.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Introduction
11.13.4 Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.13.5 Lupin Pharmaceuticals Recent Developments
11.14 Glenmark Pharmaceuticals
11.14.1 Glenmark Pharmaceuticals Company Details
11.14.2 Glenmark Pharmaceuticals Business Overview
11.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Introduction
11.14.4 Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.14.5 Glenmark Pharmaceuticals Recent Developments
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Details
11.15.2 Sun Pharmaceutical Business Overview
11.15.3 Sun Pharmaceutical Antiprotozoal Drugs Introduction
11.15.4 Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2018-2023)
11.15.5 Sun Pharmaceutical Recent Developments
11.16 Heritage Pharmaceuticals
11.16.1 Heritage Pharmaceuticals Company Details
11.16.2 Heritage Pharmaceuticals Business Overview
11.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Introduction
11.16.4 Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.16.5 Heritage Pharmaceuticals Recent Developments
11.17 Gilead Sciences
11.17.1 Gilead Sciences Company Details
11.17.2 Gilead Sciences Business Overview
11.17.3 Gilead Sciences Antiprotozoal Drugs Introduction
11.17.4 Gilead Sciences Revenue in Antiprotozoal Drugs Business (2018-2023)
11.17.5 Gilead Sciences Recent Developments
11.18 Johnson & Johnson
11.18.1 Johnson & Johnson Company Details
11.18.2 Johnson & Johnson Business Overview
11.18.3 Johnson & Johnson Antiprotozoal Drugs Introduction
11.18.4 Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2018-2023)
11.18.5 Johnson & Johnson Recent Developments
11.19 Bristol-Myers Squibb
11.19.1 Bristol-Myers Squibb Company Details
11.19.2 Bristol-Myers Squibb Business Overview
11.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Introduction
11.19.4 Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2018-2023)
11.19.5 Bristol-Myers Squibb Recent Developments
11.20 Profounda
11.20.1 Profounda Company Details
11.20.2 Profounda Business Overview
11.20.3 Profounda Antiprotozoal Drugs Introduction
11.20.4 Profounda Revenue in Antiprotozoal Drugs Business (2018-2023)
11.20.5 Profounda Recent Developments
11.21 Knight Therapeutics
11.21.1 Knight Therapeutics Company Details
11.21.2 Knight Therapeutics Business Overview
11.21.3 Knight Therapeutics Antiprotozoal Drugs Introduction
11.21.4 Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2018-2023)
11.21.5 Knight Therapeutics Recent Developments
11.22 Albert David
11.22.1 Albert David Company Details
11.22.2 Albert David Business Overview
11.22.3 Albert David Antiprotozoal Drugs Introduction
11.22.4 Albert David Revenue in Antiprotozoal Drugs Business (2018-2023)
11.22.5 Albert David Recent Developments
11.23 Wanlong
11.23.1 Wanlong Company Details
11.23.2 Wanlong Business Overview
11.23.3 Wanlong Antiprotozoal Drugs Introduction
11.23.4 Wanlong Revenue in Antiprotozoal Drugs Business (2018-2023)
11.23.5 Wanlong Recent Developments
11.24 Fangsheng
11.24.1 Fangsheng Company Details
11.24.2 Fangsheng Business Overview
11.24.3 Fangsheng Antiprotozoal Drugs Introduction
11.24.4 Fangsheng Revenue in Antiprotozoal Drugs Business (2018-2023)
11.24.5 Fangsheng Recent Developments
11.25 KPC Pharmaceuticals
11.25.1 KPC Pharmaceuticals Company Details
11.25.2 KPC Pharmaceuticals Business Overview
11.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Introduction
11.25.4 KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.25.5 KPC Pharmaceuticals Recent Developments
11.26 Guilin Pharmaceuticals
11.26.1 Guilin Pharmaceuticals Company Details
11.26.2 Guilin Pharmaceuticals Business Overview
11.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Introduction
11.26.4 Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.26.5 Guilin Pharmaceuticals Recent Developments
11.27 Pude Pharmaceutica
11.27.1 Pude Pharmaceutica Company Details
11.27.2 Pude Pharmaceutica Business Overview
11.27.3 Pude Pharmaceutica Antiprotozoal Drugs Introduction
11.27.4 Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2018-2023)
11.27.5 Pude Pharmaceutica Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiprotozoal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Amoebic Dysentery
1.2.3 Antimalarial Drug
1.2.4 Leishmaniasis & Chagas Disease
1.3 Market by Application
1.3.1 Global Antiprotozoal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Antiprotozoal Drugs Market Perspective (2018-2029)
2.2 Global Antiprotozoal Drugs Growth Trends by Region
2.2.1 Antiprotozoal Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antiprotozoal Drugs Historic Market Size by Region (2018-2023)
2.2.3 Antiprotozoal Drugs Forecasted Market Size by Region (2024-2029)
2.3 Antiprotozoal Drugs Market Dynamics
2.3.1 Antiprotozoal Drugs Industry Trends
2.3.2 Antiprotozoal Drugs Market Drivers
2.3.3 Antiprotozoal Drugs Market Challenges
2.3.4 Antiprotozoal Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Antiprotozoal Drugs by Players
3.1.1 Global Antiprotozoal Drugs Revenue by Players (2018-2023)
3.1.2 Global Antiprotozoal Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Antiprotozoal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Antiprotozoal Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Antiprotozoal Drugs Market Concentration Ratio
3.4.1 Global Antiprotozoal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiprotozoal Drugs Revenue in 2022
3.5 Global Key Players of Antiprotozoal Drugs Head office and Area Served
3.6 Global Key Players of Antiprotozoal Drugs, Product and Application
3.7 Global Key Players of Antiprotozoal Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ANTIPROTOZOAL DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Antiprotozoal Drugs Historic Market Size by Type (2018-2023)
4.2 Global Antiprotozoal Drugs Forecasted Market Size by Type (2024-2029)
5 ANTIPROTOZOAL DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Antiprotozoal Drugs Historic Market Size by Application (2018-2023)
5.2 Global Antiprotozoal Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Antiprotozoal Drugs Market Size (2018-2029)
6.2 North America Antiprotozoal Drugs Market Size by Type
6.2.1 North America Antiprotozoal Drugs Market Size by Type (2018-2023)
6.2.2 North America Antiprotozoal Drugs Market Size by Type (2024-2029)
6.2.3 North America Antiprotozoal Drugs Market Share by Type (2018-2029)
6.3 North America Antiprotozoal Drugs Market Size by Application
6.3.1 North America Antiprotozoal Drugs Market Size by Application (2018-2023)
6.3.2 North America Antiprotozoal Drugs Market Size by Application (2024-2029)
6.3.3 North America Antiprotozoal Drugs Market Share by Application (2018-2029)
6.4 North America Antiprotozoal Drugs Market Size by Country
6.4.1 North America Antiprotozoal Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Antiprotozoal Drugs Market Size by Country (2018-2023)
6.4.3 North America Antiprotozoal Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Antiprotozoal Drugs Market Size (2018-2029)
7.2 Europe Antiprotozoal Drugs Market Size by Type
7.2.1 Europe Antiprotozoal Drugs Market Size by Type (2018-2023)
7.2.2 Europe Antiprotozoal Drugs Market Size by Type (2024-2029)
7.2.3 Europe Antiprotozoal Drugs Market Share by Type (2018-2029)
7.3 Europe Antiprotozoal Drugs Market Size by Application
7.3.1 Europe Antiprotozoal Drugs Market Size by Application (2018-2023)
7.3.2 Europe Antiprotozoal Drugs Market Size by Application (2024-2029)
7.3.3 Europe Antiprotozoal Drugs Market Share by Application (2018-2029)
7.4 Europe Antiprotozoal Drugs Market Size by Country
7.4.1 Europe Antiprotozoal Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Antiprotozoal Drugs Market Size by Country (2018-2023)
7.4.3 Europe Antiprotozoal Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Antiprotozoal Drugs Market Size (2018-2029)
8.2 China Antiprotozoal Drugs Market Size by Type
8.2.1 China Antiprotozoal Drugs Market Size by Type (2018-2023)
8.2.2 China Antiprotozoal Drugs Market Size by Type (2024-2029)
8.2.3 China Antiprotozoal Drugs Market Share by Type (2018-2029)
8.3 China Antiprotozoal Drugs Market Size by Application
8.3.1 China Antiprotozoal Drugs Market Size by Application (2018-2023)
8.3.2 China Antiprotozoal Drugs Market Size by Application (2024-2029)
8.3.3 China Antiprotozoal Drugs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Antiprotozoal Drugs Market Size (2018-2029)
9.2 Asia Antiprotozoal Drugs Market Size by Type
9.2.1 Asia Antiprotozoal Drugs Market Size by Type (2018-2023)
9.2.2 Asia Antiprotozoal Drugs Market Size by Type (2024-2029)
9.2.3 Asia Antiprotozoal Drugs Market Share by Type (2018-2029)
9.3 Asia Antiprotozoal Drugs Market Size by Application
9.3.1 Asia Antiprotozoal Drugs Market Size by Application (2018-2023)
9.3.2 Asia Antiprotozoal Drugs Market Size by Application (2024-2029)
9.3.3 Asia Antiprotozoal Drugs Market Share by Application (2018-2029)
9.4 Asia Antiprotozoal Drugs Market Size by Region
9.4.1 Asia Antiprotozoal Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Antiprotozoal Drugs Market Size by Region (2018-2023)
9.4.3 Asia Antiprotozoal Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Antiprotozoal Drugs Introduction
11.1.4 Sanofi Revenue in Antiprotozoal Drugs Business (2018-2023)
11.1.5 Sanofi Recent Developments
11.2 Akthelia Pharmaceuticals Ltd
11.2.1 Akthelia Pharmaceuticals Ltd Company Details
11.2.2 Akthelia Pharmaceuticals Ltd Business Overview
11.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Introduction
11.2.4 Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2018-2023)
11.2.5 Akthelia Pharmaceuticals Ltd Recent Developments
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Introduction
11.3.4 GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2018-2023)
11.3.5 GlaxoSmithKline Plc Recent Developments
11.4 Immuron Ltd
11.4.1 Immuron Ltd Company Details
11.4.2 Immuron Ltd Business Overview
11.4.3 Immuron Ltd Antiprotozoal Drugs Introduction
11.4.4 Immuron Ltd Revenue in Antiprotozoal Drugs Business (2018-2023)
11.4.5 Immuron Ltd Recent Developments
11.5 Microbiotix Inc
11.5.1 Microbiotix Inc Company Details
11.5.2 Microbiotix Inc Business Overview
11.5.3 Microbiotix Inc Antiprotozoal Drugs Introduction
11.5.4 Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2018-2023)
11.5.5 Microbiotix Inc Recent Developments
11.6 Protein Potential LLC
11.6.1 Protein Potential LLC Company Details
11.6.2 Protein Potential LLC Business Overview
11.6.3 Protein Potential LLC Antiprotozoal Drugs Introduction
11.6.4 Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2018-2023)
11.6.5 Protein Potential LLC Recent Developments
11.7 Dr. Reddy’s Laboratories
11.7.1 Dr. Reddy’s Laboratories Company Details
11.7.2 Dr. Reddy’s Laboratories Business Overview
11.7.3 Dr. Reddy’s Laboratories Antiprotozoal Drugs Introduction
11.7.4 Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023)
11.7.5 Dr. Reddy’s Laboratories Recent Developments
11.8 Mission Pharmacal
11.8.1 Mission Pharmacal Company Details
11.8.2 Mission Pharmacal Business Overview
11.8.3 Mission Pharmacal Antiprotozoal Drugs Introduction
11.8.4 Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2018-2023)
11.8.5 Mission Pharmacal Recent Developments
11.9 Aceto Corp.
11.9.1 Aceto Corp. Company Details
11.9.2 Aceto Corp. Business Overview
11.9.3 Aceto Corp. Antiprotozoal Drugs Introduction
11.9.4 Aceto Corp. Revenue in Antiprotozoal Drugs Business (2018-2023)
11.9.5 Aceto Corp. Recent Developments
11.10 Mylan Pharmaceuticals
11.10.1 Mylan Pharmaceuticals Company Details
11.10.2 Mylan Pharmaceuticals Business Overview
11.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Introduction
11.10.4 Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.10.5 Mylan Pharmaceuticals Recent Developments
11.11 Impax Laboratories
11.11.1 Impax Laboratories Company Details
11.11.2 Impax Laboratories Business Overview
11.11.3 Impax Laboratories Antiprotozoal Drugs Introduction
11.11.4 Impax Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023)
11.11.5 Impax Laboratories Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Antiprotozoal Drugs Introduction
11.12.4 Pfizer Revenue in Antiprotozoal Drugs Business (2018-2023)
11.12.5 Pfizer Recent Developments
11.13 Lupin Pharmaceuticals
11.13.1 Lupin Pharmaceuticals Company Details
11.13.2 Lupin Pharmaceuticals Business Overview
11.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Introduction
11.13.4 Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.13.5 Lupin Pharmaceuticals Recent Developments
11.14 Glenmark Pharmaceuticals
11.14.1 Glenmark Pharmaceuticals Company Details
11.14.2 Glenmark Pharmaceuticals Business Overview
11.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Introduction
11.14.4 Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.14.5 Glenmark Pharmaceuticals Recent Developments
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Details
11.15.2 Sun Pharmaceutical Business Overview
11.15.3 Sun Pharmaceutical Antiprotozoal Drugs Introduction
11.15.4 Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2018-2023)
11.15.5 Sun Pharmaceutical Recent Developments
11.16 Heritage Pharmaceuticals
11.16.1 Heritage Pharmaceuticals Company Details
11.16.2 Heritage Pharmaceuticals Business Overview
11.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Introduction
11.16.4 Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.16.5 Heritage Pharmaceuticals Recent Developments
11.17 Gilead Sciences
11.17.1 Gilead Sciences Company Details
11.17.2 Gilead Sciences Business Overview
11.17.3 Gilead Sciences Antiprotozoal Drugs Introduction
11.17.4 Gilead Sciences Revenue in Antiprotozoal Drugs Business (2018-2023)
11.17.5 Gilead Sciences Recent Developments
11.18 Johnson & Johnson
11.18.1 Johnson & Johnson Company Details
11.18.2 Johnson & Johnson Business Overview
11.18.3 Johnson & Johnson Antiprotozoal Drugs Introduction
11.18.4 Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2018-2023)
11.18.5 Johnson & Johnson Recent Developments
11.19 Bristol-Myers Squibb
11.19.1 Bristol-Myers Squibb Company Details
11.19.2 Bristol-Myers Squibb Business Overview
11.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Introduction
11.19.4 Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2018-2023)
11.19.5 Bristol-Myers Squibb Recent Developments
11.20 Profounda
11.20.1 Profounda Company Details
11.20.2 Profounda Business Overview
11.20.3 Profounda Antiprotozoal Drugs Introduction
11.20.4 Profounda Revenue in Antiprotozoal Drugs Business (2018-2023)
11.20.5 Profounda Recent Developments
11.21 Knight Therapeutics
11.21.1 Knight Therapeutics Company Details
11.21.2 Knight Therapeutics Business Overview
11.21.3 Knight Therapeutics Antiprotozoal Drugs Introduction
11.21.4 Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2018-2023)
11.21.5 Knight Therapeutics Recent Developments
11.22 Albert David
11.22.1 Albert David Company Details
11.22.2 Albert David Business Overview
11.22.3 Albert David Antiprotozoal Drugs Introduction
11.22.4 Albert David Revenue in Antiprotozoal Drugs Business (2018-2023)
11.22.5 Albert David Recent Developments
11.23 Wanlong
11.23.1 Wanlong Company Details
11.23.2 Wanlong Business Overview
11.23.3 Wanlong Antiprotozoal Drugs Introduction
11.23.4 Wanlong Revenue in Antiprotozoal Drugs Business (2018-2023)
11.23.5 Wanlong Recent Developments
11.24 Fangsheng
11.24.1 Fangsheng Company Details
11.24.2 Fangsheng Business Overview
11.24.3 Fangsheng Antiprotozoal Drugs Introduction
11.24.4 Fangsheng Revenue in Antiprotozoal Drugs Business (2018-2023)
11.24.5 Fangsheng Recent Developments
11.25 KPC Pharmaceuticals
11.25.1 KPC Pharmaceuticals Company Details
11.25.2 KPC Pharmaceuticals Business Overview
11.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Introduction
11.25.4 KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.25.5 KPC Pharmaceuticals Recent Developments
11.26 Guilin Pharmaceuticals
11.26.1 Guilin Pharmaceuticals Company Details
11.26.2 Guilin Pharmaceuticals Business Overview
11.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Introduction
11.26.4 Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023)
11.26.5 Guilin Pharmaceuticals Recent Developments
11.27 Pude Pharmaceutica
11.27.1 Pude Pharmaceutica Company Details
11.27.2 Pude Pharmaceutica Business Overview
11.27.3 Pude Pharmaceutica Antiprotozoal Drugs Introduction
11.27.4 Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2018-2023)
11.27.5 Pude Pharmaceutica Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Antiprotozoal Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Amoebic Dysentery
Table 3. Key Players of Antimalarial Drug
Table 4. Key Players of Leishmaniasis & Chagas Disease
Table 5. Global Antiprotozoal Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Antiprotozoal Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Antiprotozoal Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Antiprotozoal Drugs Market Share by Region (2018-2023)
Table 9. Global Antiprotozoal Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Antiprotozoal Drugs Market Share by Region (2024-2029)
Table 11. Antiprotozoal Drugs Market Trends
Table 12. Antiprotozoal Drugs Market Drivers
Table 13. Antiprotozoal Drugs Market Challenges
Table 14. Antiprotozoal Drugs Market Restraints
Table 15. Global Antiprotozoal Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Antiprotozoal Drugs Revenue Share by Players (2018-2023)
Table 17. Global Top Antiprotozoal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2022)
Table 18. Global Antiprotozoal Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Antiprotozoal Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Antiprotozoal Drugs, Headquarters and Area Served
Table 21. Global Key Players of Antiprotozoal Drugs, Product and Application
Table 22. Global Key Players of Antiprotozoal Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Antiprotozoal Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Antiprotozoal Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Antiprotozoal Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Antiprotozoal Drugs Revenue Share by Application (2018-2023)
Table 30. Global Antiprotozoal Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Antiprotozoal Drugs Revenue Share by Application (2024-2029)
Table 32. North America Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Antiprotozoal Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Antiprotozoal Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Antiprotozoal Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Antiprotozoal Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Antiprotozoal Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Antiprotozoal Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Antiprotozoal Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Antiprotozoal Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Antiprotozoal Drugs Product
Table 67. Sanofi Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 68. Sanofi Recent Developments
Table 69. Akthelia Pharmaceuticals Ltd Company Details
Table 70. Akthelia Pharmaceuticals Ltd Business Overview
Table 71. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product
Table 72. Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 73. Akthelia Pharmaceuticals Ltd Recent Developments
Table 74. GlaxoSmithKline Plc Company Details
Table 75. GlaxoSmithKline Plc Business Overview
Table 76. GlaxoSmithKline Plc Antiprotozoal Drugs Product
Table 77. GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 78. GlaxoSmithKline Plc Recent Developments
Table 79. Immuron Ltd Company Details
Table 80. Immuron Ltd Business Overview
Table 81. Immuron Ltd Antiprotozoal Drugs Product
Table 82. Immuron Ltd Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 83. Immuron Ltd Recent Developments
Table 84. Microbiotix Inc Company Details
Table 85. Microbiotix Inc Business Overview
Table 86. Microbiotix Inc Antiprotozoal Drugs Product
Table 87. Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 88. Microbiotix Inc Recent Developments
Table 89. Protein Potential LLC Company Details
Table 90. Protein Potential LLC Business Overview
Table 91. Protein Potential LLC Antiprotozoal Drugs Product
Table 92. Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 93. Protein Potential LLC Recent Developments
Table 94. Dr. Reddy’s Laboratories Company Details
Table 95. Dr. Reddy’s Laboratories Business Overview
Table 96. Dr. Reddy’s Laboratories Antiprotozoal Drugs Product
Table 97. Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 98. Dr. Reddy’s Laboratories Recent Developments
Table 99. Mission Pharmacal Company Details
Table 100. Mission Pharmacal Business Overview
Table 101. Mission Pharmacal Antiprotozoal Drugs Product
Table 102. Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 103. Mission Pharmacal Recent Developments
Table 104. Aceto Corp. Company Details
Table 105. Aceto Corp. Business Overview
Table 106. Aceto Corp. Antiprotozoal Drugs Product
Table 107. Aceto Corp. Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 108. Aceto Corp. Recent Developments
Table 109. Mylan Pharmaceuticals Company Details
Table 110. Mylan Pharmaceuticals Business Overview
Table 111. Mylan Pharmaceuticals Antiprotozoal Drugs Product
Table 112. Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 113. Mylan Pharmaceuticals Recent Developments
Table 114. Impax Laboratories Company Details
Table 115. Impax Laboratories Business Overview
Table 116. Impax Laboratories Antiprotozoal Drugs Product
Table 117. Impax Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 118. Impax Laboratories Recent Developments
Table 119. Pfizer Company Details
Table 120. Pfizer Business Overview
Table 121. Pfizer Antiprotozoal Drugs Product
Table 122. Pfizer Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 123. Pfizer Recent Developments
Table 124. Lupin Pharmaceuticals Company Details
Table 125. Lupin Pharmaceuticals Business Overview
Table 126. Lupin Pharmaceuticals Antiprotozoal Drugs Product
Table 127. Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 128. Lupin Pharmaceuticals Recent Developments
Table 129. Glenmark Pharmaceuticals Company Details
Table 130. Glenmark Pharmaceuticals Business Overview
Table 131. Glenmark Pharmaceuticals Antiprotozoal Drugs Product
Table 132. Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 133. Glenmark Pharmaceuticals Recent Developments
Table 134. Sun Pharmaceutical Company Details
Table 135. Sun Pharmaceutical Business Overview
Table 136. Sun Pharmaceutical Antiprotozoal Drugs Product
Table 137. Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 138. Sun Pharmaceutical Recent Developments
Table 139. Heritage Pharmaceuticals Company Details
Table 140. Heritage Pharmaceuticals Business Overview
Table 141. Heritage Pharmaceuticals Antiprotozoal Drugs Product
Table 142. Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 143. Heritage Pharmaceuticals Recent Developments
Table 144. Gilead Sciences Company Details
Table 145. Gilead Sciences Business Overview
Table 146. Gilead Sciences Antiprotozoal Drugs Product
Table 147. Gilead Sciences Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 148. Gilead Sciences Recent Developments
Table 149. Johnson & Johnson Company Details
Table 150. Johnson & Johnson Business Overview
Table 151. Johnson & Johnson Antiprotozoal Drugs Product
Table 152. Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 153. Johnson & Johnson Recent Developments
Table 154. Bristol-Myers Squibb Company Details
Table 155. Bristol-Myers Squibb Business Overview
Table 156. Bristol-Myers Squibb Antiprotozoal Drugs Product
Table 157. Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 158. Bristol-Myers Squibb Recent Developments
Table 159. Profounda Company Details
Table 160. Profounda Business Overview
Table 161. Profounda Antiprotozoal Drugs Product
Table 162. Profounda Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 163. Profounda Recent Developments
Table 164. Knight Therapeutics Company Details
Table 165. Knight Therapeutics Business Overview
Table 166. Knight Therapeutics Antiprotozoal Drugs Product
Table 167. Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 168. Knight Therapeutics Recent Developments
Table 169. Albert David Company Details
Table 170. Albert David Business Overview
Table 171. Albert David Antiprotozoal Drugs Product
Table 172. Albert David Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 173. Albert David Recent Developments
Table 174. Wanlong Company Details
Table 175. Wanlong Business Overview
Table 176. Wanlong Antiprotozoal Drugs Product
Table 177. Wanlong Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 178. Wanlong Recent Developments
Table 179. Fangsheng Company Details
Table 180. Fangsheng Business Overview
Table 181. Fangsheng Antiprotozoal Drugs Product
Table 182. Fangsheng Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 183. Fangsheng Recent Developments
Table 184. KPC Pharmaceuticals Company Details
Table 185. KPC Pharmaceuticals Business Overview
Table 186. KPC Pharmaceuticals Antiprotozoal Drugs Product
Table 187. KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 188. KPC Pharmaceuticals Recent Developments
Table 189. Guilin Pharmaceuticals Company Details
Table 190. Guilin Pharmaceuticals Business Overview
Table 191. Guilin Pharmaceuticals Antiprotozoal Drugs Product
Table 192. Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 193. Guilin Pharmaceuticals Recent Developments
Table 194. Pude Pharmaceutica Company Details
Table 195. Pude Pharmaceutica Business Overview
Table 196. Pude Pharmaceutica Antiprotozoal Drugs Product
Table 197. Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 198. Pude Pharmaceutica Recent Developments
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
Table 1. Global Antiprotozoal Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Amoebic Dysentery
Table 3. Key Players of Antimalarial Drug
Table 4. Key Players of Leishmaniasis & Chagas Disease
Table 5. Global Antiprotozoal Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Antiprotozoal Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Antiprotozoal Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Antiprotozoal Drugs Market Share by Region (2018-2023)
Table 9. Global Antiprotozoal Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Antiprotozoal Drugs Market Share by Region (2024-2029)
Table 11. Antiprotozoal Drugs Market Trends
Table 12. Antiprotozoal Drugs Market Drivers
Table 13. Antiprotozoal Drugs Market Challenges
Table 14. Antiprotozoal Drugs Market Restraints
Table 15. Global Antiprotozoal Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Antiprotozoal Drugs Revenue Share by Players (2018-2023)
Table 17. Global Top Antiprotozoal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2022)
Table 18. Global Antiprotozoal Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Antiprotozoal Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Antiprotozoal Drugs, Headquarters and Area Served
Table 21. Global Key Players of Antiprotozoal Drugs, Product and Application
Table 22. Global Key Players of Antiprotozoal Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Antiprotozoal Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Antiprotozoal Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Antiprotozoal Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Antiprotozoal Drugs Revenue Share by Application (2018-2023)
Table 30. Global Antiprotozoal Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Antiprotozoal Drugs Revenue Share by Application (2024-2029)
Table 32. North America Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Antiprotozoal Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Antiprotozoal Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Antiprotozoal Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Antiprotozoal Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Antiprotozoal Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Antiprotozoal Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Antiprotozoal Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Antiprotozoal Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Antiprotozoal Drugs Product
Table 67. Sanofi Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 68. Sanofi Recent Developments
Table 69. Akthelia Pharmaceuticals Ltd Company Details
Table 70. Akthelia Pharmaceuticals Ltd Business Overview
Table 71. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product
Table 72. Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 73. Akthelia Pharmaceuticals Ltd Recent Developments
Table 74. GlaxoSmithKline Plc Company Details
Table 75. GlaxoSmithKline Plc Business Overview
Table 76. GlaxoSmithKline Plc Antiprotozoal Drugs Product
Table 77. GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 78. GlaxoSmithKline Plc Recent Developments
Table 79. Immuron Ltd Company Details
Table 80. Immuron Ltd Business Overview
Table 81. Immuron Ltd Antiprotozoal Drugs Product
Table 82. Immuron Ltd Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 83. Immuron Ltd Recent Developments
Table 84. Microbiotix Inc Company Details
Table 85. Microbiotix Inc Business Overview
Table 86. Microbiotix Inc Antiprotozoal Drugs Product
Table 87. Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 88. Microbiotix Inc Recent Developments
Table 89. Protein Potential LLC Company Details
Table 90. Protein Potential LLC Business Overview
Table 91. Protein Potential LLC Antiprotozoal Drugs Product
Table 92. Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 93. Protein Potential LLC Recent Developments
Table 94. Dr. Reddy’s Laboratories Company Details
Table 95. Dr. Reddy’s Laboratories Business Overview
Table 96. Dr. Reddy’s Laboratories Antiprotozoal Drugs Product
Table 97. Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 98. Dr. Reddy’s Laboratories Recent Developments
Table 99. Mission Pharmacal Company Details
Table 100. Mission Pharmacal Business Overview
Table 101. Mission Pharmacal Antiprotozoal Drugs Product
Table 102. Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 103. Mission Pharmacal Recent Developments
Table 104. Aceto Corp. Company Details
Table 105. Aceto Corp. Business Overview
Table 106. Aceto Corp. Antiprotozoal Drugs Product
Table 107. Aceto Corp. Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 108. Aceto Corp. Recent Developments
Table 109. Mylan Pharmaceuticals Company Details
Table 110. Mylan Pharmaceuticals Business Overview
Table 111. Mylan Pharmaceuticals Antiprotozoal Drugs Product
Table 112. Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 113. Mylan Pharmaceuticals Recent Developments
Table 114. Impax Laboratories Company Details
Table 115. Impax Laboratories Business Overview
Table 116. Impax Laboratories Antiprotozoal Drugs Product
Table 117. Impax Laboratories Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 118. Impax Laboratories Recent Developments
Table 119. Pfizer Company Details
Table 120. Pfizer Business Overview
Table 121. Pfizer Antiprotozoal Drugs Product
Table 122. Pfizer Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 123. Pfizer Recent Developments
Table 124. Lupin Pharmaceuticals Company Details
Table 125. Lupin Pharmaceuticals Business Overview
Table 126. Lupin Pharmaceuticals Antiprotozoal Drugs Product
Table 127. Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 128. Lupin Pharmaceuticals Recent Developments
Table 129. Glenmark Pharmaceuticals Company Details
Table 130. Glenmark Pharmaceuticals Business Overview
Table 131. Glenmark Pharmaceuticals Antiprotozoal Drugs Product
Table 132. Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 133. Glenmark Pharmaceuticals Recent Developments
Table 134. Sun Pharmaceutical Company Details
Table 135. Sun Pharmaceutical Business Overview
Table 136. Sun Pharmaceutical Antiprotozoal Drugs Product
Table 137. Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 138. Sun Pharmaceutical Recent Developments
Table 139. Heritage Pharmaceuticals Company Details
Table 140. Heritage Pharmaceuticals Business Overview
Table 141. Heritage Pharmaceuticals Antiprotozoal Drugs Product
Table 142. Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 143. Heritage Pharmaceuticals Recent Developments
Table 144. Gilead Sciences Company Details
Table 145. Gilead Sciences Business Overview
Table 146. Gilead Sciences Antiprotozoal Drugs Product
Table 147. Gilead Sciences Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 148. Gilead Sciences Recent Developments
Table 149. Johnson & Johnson Company Details
Table 150. Johnson & Johnson Business Overview
Table 151. Johnson & Johnson Antiprotozoal Drugs Product
Table 152. Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 153. Johnson & Johnson Recent Developments
Table 154. Bristol-Myers Squibb Company Details
Table 155. Bristol-Myers Squibb Business Overview
Table 156. Bristol-Myers Squibb Antiprotozoal Drugs Product
Table 157. Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 158. Bristol-Myers Squibb Recent Developments
Table 159. Profounda Company Details
Table 160. Profounda Business Overview
Table 161. Profounda Antiprotozoal Drugs Product
Table 162. Profounda Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 163. Profounda Recent Developments
Table 164. Knight Therapeutics Company Details
Table 165. Knight Therapeutics Business Overview
Table 166. Knight Therapeutics Antiprotozoal Drugs Product
Table 167. Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 168. Knight Therapeutics Recent Developments
Table 169. Albert David Company Details
Table 170. Albert David Business Overview
Table 171. Albert David Antiprotozoal Drugs Product
Table 172. Albert David Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 173. Albert David Recent Developments
Table 174. Wanlong Company Details
Table 175. Wanlong Business Overview
Table 176. Wanlong Antiprotozoal Drugs Product
Table 177. Wanlong Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 178. Wanlong Recent Developments
Table 179. Fangsheng Company Details
Table 180. Fangsheng Business Overview
Table 181. Fangsheng Antiprotozoal Drugs Product
Table 182. Fangsheng Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 183. Fangsheng Recent Developments
Table 184. KPC Pharmaceuticals Company Details
Table 185. KPC Pharmaceuticals Business Overview
Table 186. KPC Pharmaceuticals Antiprotozoal Drugs Product
Table 187. KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 188. KPC Pharmaceuticals Recent Developments
Table 189. Guilin Pharmaceuticals Company Details
Table 190. Guilin Pharmaceuticals Business Overview
Table 191. Guilin Pharmaceuticals Antiprotozoal Drugs Product
Table 192. Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 193. Guilin Pharmaceuticals Recent Developments
Table 194. Pude Pharmaceutica Company Details
Table 195. Pude Pharmaceutica Business Overview
Table 196. Pude Pharmaceutica Antiprotozoal Drugs Product
Table 197. Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2018-2023) & (US$ Million)
Table 198. Pude Pharmaceutica Recent Developments
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Antiprotozoal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Antiprotozoal Drugs Market Share by Type: 2022 VS 2029
Figure 3. Amoebic Dysentery Features
Figure 4. Antimalarial Drug Features
Figure 5. Leishmaniasis & Chagas Disease Features
Figure 6. Global Antiprotozoal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Antiprotozoal Drugs Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Antiprotozoal Drugs Report Years Considered
Figure 11. Global Antiprotozoal Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Antiprotozoal Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Antiprotozoal Drugs Market Share by Region: 2022 VS 2029
Figure 14. Global Antiprotozoal Drugs Market Share by Players in 2022
Figure 15. Global Top Antiprotozoal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Antiprotozoal Drugs Revenue in 2022
Figure 17. North America Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 19. North America Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 20. North America Antiprotozoal Drugs Market Share by Country (2018-2029)
Figure 21. United States Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Antiprotozoal Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 25. Europe Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 26. Europe Antiprotozoal Drugs Market Share by Country (2018-2029)
Figure 27. Germany Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Antiprotozoal Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 35. China Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 36. Asia Antiprotozoal Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 38. Asia Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 39. Asia Antiprotozoal Drugs Market Share by Region (2018-2029)
Figure 40. Japan Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Country (2018-2029)
Figure 50. Brazil Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Sanofi Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 57. Akthelia Pharmaceuticals Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 58. GlaxoSmithKline Plc Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 59. Immuron Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 60. Microbiotix Inc Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 61. Protein Potential LLC Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 62. Dr. Reddy’s Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 63. Mission Pharmacal Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 64. Aceto Corp. Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 65. Mylan Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 66. Impax Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 67. Pfizer Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 68. Lupin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 69. Glenmark Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 70. Sun Pharmaceutical Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 71. Heritage Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 72. Gilead Sciences Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 73. Johnson & Johnson Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 74. Bristol-Myers Squibb Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 75. Profounda Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 76. Knight Therapeutics Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 77. Albert David Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 78. Wanlong Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 79. Fangsheng Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 80. KPC Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 81. Guilin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 82. Pude Pharmaceutica Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Figure 1. Global Antiprotozoal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Antiprotozoal Drugs Market Share by Type: 2022 VS 2029
Figure 3. Amoebic Dysentery Features
Figure 4. Antimalarial Drug Features
Figure 5. Leishmaniasis & Chagas Disease Features
Figure 6. Global Antiprotozoal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Antiprotozoal Drugs Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Antiprotozoal Drugs Report Years Considered
Figure 11. Global Antiprotozoal Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Antiprotozoal Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Antiprotozoal Drugs Market Share by Region: 2022 VS 2029
Figure 14. Global Antiprotozoal Drugs Market Share by Players in 2022
Figure 15. Global Top Antiprotozoal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiprotozoal Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Antiprotozoal Drugs Revenue in 2022
Figure 17. North America Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 19. North America Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 20. North America Antiprotozoal Drugs Market Share by Country (2018-2029)
Figure 21. United States Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Antiprotozoal Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 25. Europe Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 26. Europe Antiprotozoal Drugs Market Share by Country (2018-2029)
Figure 27. Germany Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Antiprotozoal Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 35. China Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 36. Asia Antiprotozoal Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 38. Asia Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 39. Asia Antiprotozoal Drugs Market Share by Region (2018-2029)
Figure 40. Japan Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Antiprotozoal Drugs Market Share by Country (2018-2029)
Figure 50. Brazil Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Antiprotozoal Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Sanofi Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 57. Akthelia Pharmaceuticals Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 58. GlaxoSmithKline Plc Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 59. Immuron Ltd Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 60. Microbiotix Inc Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 61. Protein Potential LLC Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 62. Dr. Reddy’s Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 63. Mission Pharmacal Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 64. Aceto Corp. Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 65. Mylan Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 66. Impax Laboratories Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 67. Pfizer Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 68. Lupin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 69. Glenmark Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 70. Sun Pharmaceutical Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 71. Heritage Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 72. Gilead Sciences Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 73. Johnson & Johnson Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 74. Bristol-Myers Squibb Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 75. Profounda Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 76. Knight Therapeutics Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 77. Albert David Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 78. Wanlong Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 79. Fangsheng Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 80. KPC Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 81. Guilin Pharmaceuticals Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 82. Pude Pharmaceutica Revenue Growth Rate in Antiprotozoal Drugs Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
